The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Health-related quality of life (HRQL) in patients with advanced cutaneous squamous cell carcinoma (CSCC) treated with cemiplimab: Post hoc exploratory analyses of a phase II clinical trial.
 
Michael Robert Migden
Consulting or Advisory Role - Rakuten Medical; Regeneron; Sun Pharma
Research Funding - PellePharm; Regeneron
Travel, Accommodations, Expenses - Regeneron; Sun Pharma
 
Danny Rischin
Research Funding - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Merck; Regeneron
Travel, Accommodations, Expenses - Merck
 
Medha Sasane
Employment - Sanofi
Leadership - Sanofi
Stock and Other Ownership Interests - Sanofi
 
Vera Mastey
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Anna Pavlick
Honoraria - Array BioPharma; Bristol-Myers Squibb; Regeneron; Sanofi; Seagen
Consulting or Advisory Role - Regeneron; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Regeneron (Inst); Replimune (Inst)
Travel, Accommodations, Expenses - Regeneron; Seagen
 
Chrysalyne D. Schmults
Leadership - NCCN
Consulting or Advisory Role - Regeneron; Sanofi
Speakers' Bureau - Castle Biosciences; Regeneron
Research Funding - Castle Biosciences; Genentech; Merck; Novartis; Regeneron
 
Zhen Chen
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Alexander David Guminski
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Merck; MSD Oncology; Pfizer; Prime Oncology; Regeneron; Sun Pharma
Research Funding - Sun Pharma (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Medivation/Astellas; Merck KGaA; Sun Pharma
 
Axel Hauschild
Honoraria - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Philogen; Provectus; Regeneron; Roche; Sanofi/Aventis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Philogen; Provectus; Regeneron; Roche; Sanofi/Aventis
Research Funding - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Regeneron; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Roche; Sanofi/Aventis
 
Denise Bury
Employment - Sanofi
Stock and Other Ownership Interests - Sanofi
Travel, Accommodations, Expenses - Sanofi
 
Anne Lynn S. Chang
Consulting or Advisory Role - Merck; Regeneron
Research Funding - Galderma; Merck; Novartis; Regeneron
 
Guilherme Rabinowits
Stock and Other Ownership Interests - Regeneron; Syros Pharmaceuticals
Consulting or Advisory Role - Castle Biosciences; EMD Serono; Merck Serono; Pfizer; Regeneron; Sanofi/Regeneron
Research Funding - EMD Serono (Inst); Exelixis (Inst); Millennium (Inst)
 
Sherrif F. Ibrahim
Honoraria - Galderma; Genentech; Regeneron
Consulting or Advisory Role - Regeneron; Regeneron; Regeneron; Regeneron
Speakers' Bureau - Genentech; Regeneron
Research Funding - Castle Biosciences (Inst)
 
Israel Lowy
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron
 
Matthew G. Fury
Employment - Regeneron; Regeneron (I)
Stock and Other Ownership Interests - Regeneron; Regeneron (I)
Research Funding - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneorn; Regeneron (I)
 
Siyu Li
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Chieh-I Chen
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron